logo

For the Inventor, By the Inventor

West Lafayette, IN, United States of America

Endocyte, Inc.


USPTO Granted Patents = 60



Trademarks = 3

Forward Citations = 780

Loading Chart...
Loading Chart...

50 inventors (with patents filed for the assignee):

goldMedal Christopher Paul Leamon (54 out of 57 patents)

silverMedal Iontcho Radoslavov Vlahov (39 out of 40 patents)

bronzeMedal Philip Stewart Low (16 out of 106 patents)

4.  Hari Krishna R Santhapuram (12 out of 12 patents)

5.  Paul Joseph Kleindl (9 out of 9 patents)

6.  Joseph Anand Reddy (8 out of 8 patents)

7.  Kevin Yu Wang (8 out of 8 patents)

8.  Fei You (7 out of 7 patents)

9.  Yingjuan June Lu (7 out of 9 patents)

10.  Matthew A Parker (7 out of 7 patents)

11.  Stephen J Howard (6 out of 43 patents)

12.  Apparao Satyam (6 out of 11 patents)

13.  Haiyan Chu (6 out of 7 patents)

14.  Marilynn Vetzel (4 out of 4 patents)

15.  Melissa Nelson (4 out of 4 patents)


Core Competencies:
PSMA Conjugates
CAR T Cell Therapy
Cancer Treatment
Positron Emission Tomography
Folate Receptor Binding
Drug Delivery Conjugates
Tubulysins
Bivalent Linkers
Vitamin-Targeted Imaging
Multi-Drug Ligand Conjugates
Hydrophilic Spacer Linkers
Kidney Disease Diagnosis

60 patents:

1. 12473265 - Methods for preparing PSMA conjugates (2025-11-18),
2. 12269862 - Methods of use for CAR T cells (2025-04-08),
3. 12240870 - Sequencing method for CAR T cell therapy (2025-03-04),
4. 12208102 - Methods of treating cancer (2025-01-28),
5. 12178892 - Compounds for positron emission tomography (2024-12-31),
6. 12144850 - Methods and compositions for car T cell therapy (2024-11-19),
7. 11850262 - Compositions and methods for CAR T cell therapy (2023-12-26),
8. 11779602 - Methods of use for CAR T cells (2023-10-10),
9. 11759480 - Compositions and methods for CAR T cell therapy (2023-09-19),
10. 11219622 - Folate receptor binding conjugates of antifolates (2022-01-11),
11. 10912840 - Conjugates for treating diseases caused by PSMA expressing cells (2021-02-09),
12. 10898596 - Conjugates for imaging (2021-01-26),
13. 10857234 - Carbonic anhydrase IX inhibitor conjugates and uses thereof (2020-12-08),
14. 10738086 - Conjugates containing hydrophilic spacer linkers (2020-08-11),
15. 10647676 - Bivalent linkers and conjugates thereof (2020-05-12),
Endocyte, Inc. is a biopharmaceutical company based in West Lafayette, Indiana. The company is focused on developing targeted therapies for the treatment of cancer and other serious diseases. Endocyte utilizes its proprietary technology platform to create small molecule drug conjugates (SMDCs), which specifically target diseased cells while minimizing impact on healthy cells. With a strong pipeline of potential therapeutics, Endocyte is dedicated to improving patient outcomes through innovative and personalized medicine.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
60 Patents

#5 in West Lafayette, IN

#105 in Indiana

#5,788 in US

#11,665 in the World

...
West Lafayette, IN, United States of America

Endocyte, Inc.

Forward Citations = 780

50 inventors:

goldMedal Christopher Paul Leamon (54 out of 57 patents)

silverMedal Iontcho Radoslavov Vlahov (39 out of 40 patents)

bronzeMedal Philip Stewart Low (16 out of 106 patents)

4.  Hari Krishna R Santhapuram (12 out of 12 patents)

5.  Paul Joseph Kleindl (9 out of 9 patents)

Please report any incorrect information to support@idiyas.com
Loading…